Publications by authors named "Ellie Dow"

Claim this Profile
I
Implementation of point-of-care HbA1C instruments into community pharmacies: Initial development of a pathway for robust community testing.
Andrew Radley, Lewis Beer, Danya Rushdi, Hazel Close, Stephen McBurney, Ellie Dow

Ann Clin Biochem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced liver fibrosis (ELF) score predicts hepatic decompensation and mortality.
Madeline Pearson, Jennifer Nobes, Iain Macpherson, Lucy Gold, Michael Miller, Ellie Dow

JHEP Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intelligent Liver Function Testing (iLFT): An Intelligent Laboratory Approach to Identifying Chronic Liver Disease.
Jennifer Nobes, Damien Leith, Sava Handjiev, John F Dillon, Ellie Dow

Diagnostics (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalising laboratory medicine in the 'real world': Assessing clinical utility, by clinical indication, of serum total B and Active-B® (holotranscobalamin) in the diagnosis of vitamin B deficiency.
Michael J Murphy, Fiona Brandie, Mildred Ebare, Michelle Harrison, Ellie Dow

Ann Clin Biochem· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Call for Manuscript Submissions for a Thematic eJIFCC Issue on "Measurably Better Healthcare".
Ellie Dow, Tim James

EJIFCC· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intelligent liver function testing (iLFT): A trial of automated diagnosis and staging of liver disease in primary care.
John F Dillon, Michael H Miller, Emma M Robinson, Adrian Hapca, Mohsen Rezaeihemami, Ellie Dow

J Hepatol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of diagnostic triage criteria for liver disease from a minimum data set enabling the 'intelligent LFT' pathway for the automated assessment of deranged liver enzymes.
Michael Hugh Miller, Andrew Fraser, Gillian Leggett, Alastair MacGilchrist, George Gibson, Ellie Dow

Frontline Gastroenterol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cohort Profile: Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS).
Harry L Hébert, Bridget Shepherd, Keith Milburn, Abirami Veluchamy, Weihua Meng, Ellie Dow

Int J Epidemiol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L-DOPA therapy interferes with urine catecholamine analysis in children with suspected neuroblastoma: a case series.
Alison U Kelly, Rajeev Srivastava, Ellie Dow, D Fraser Davidson

Ann Clin Biochem· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An increased B-type natriuretic peptide in the absence of a cardiac abnormality identifies those whose left ventricular mass will increase over time.
M Adnan Nadir, Stephen Gandy, Sheila Ireland, Tom MacDonald, Ellie Dow

JACC Heart Fail· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease.
M Adnan Nadir, Sushma Rekhraj, Li Wei, Tiong K Lim, John Davidson, Ellie Dow

J Am Coll Cardiol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of high sensitivity troponin T 7 weeks after an acute coronary syndrome.
Donald S C Ang, Michelle P C Kao, Ellie Dow, Chim Lang, Allan Struthers

Heart· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis